E233-1833 Screening compound: 2-[(3-chlorophenyl)methyl]-N-[(2,3-dimethoxyphenyl)methyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

E233-1833 Screening compound: 2-[(3-chlorophenyl)methyl]-N-[(2,3-dimethoxyphenyl)methyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide
E233-1833 Screening compound: 2-[(3-chlorophenyl)methyl]-N-[(2,3-dimethoxyphenyl)methyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E233-1833
2-[(3-chlorophenyl)methyl]-N-[(2,3-dimethoxyphenyl)methyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E233-1833

Molecular Formula

C27H26ClN3O4 (C27 H26 ClN3 O4)

Compound Name

2-[(3-chlorophenyl)methyl]-N-[(2,3-dimethoxyphenyl)methyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

IUPAC name

2-[(3-chlorophenyl)methyl]-N-[(23-dimethoxyphenyl)methyl]-8-methyl-2H4H5H-furo[23-g]indazole-7-carboxamide

SMILES

Cc1c(C(NCc(cccc2OC)c2OC)=O)oc2c1-c1nn(Cc3cccc(Cl)c3)cc1CC2

InChI

InChI=1S/C27H26ClN3O4/c1-16-23-21(11-10-19-15-31(30-24(19)23)14-17-6-4-8-20(28)12-17)35-25(16)27(32)29-13-18-7-5-9-22(33-2)26(18)34-3/h4-9,12,15H,10-11,13-14H2,1-3H3,(H,29,32)

InChI Key

GJHWBQHAUBHMGA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14850681

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

491.97

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.039

Distribution Coefficient, logD

5.039

Water Solubility, LogSw

-5.32

Polar Surface Area

63.597

Acid Dissociation Constant (pKa)

12.78

Base Dissociation Constant (pKb)

-0.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.90

E233-1833 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS targets activity set (6557 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with E233-1833 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E233-1833?
Check Price and Availability of E233-1833, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E233-1833 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E233-1833
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E233-1833
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E233-1833 available by request